Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wilhelm Schmidt"'
Autor:
Sylke Nagel, Aruna Raghavachar, Ludwig Fischer von Weikersthal, Monika Serke, Ernst-Wilhelm Schmidt, Christine Lautenschlaeger, Hans Schweisfurth, Wolfgang Schuette, Ina Dittrich, Klaus Hans, Thomas Blankenburg, Angelika Reißig
Publikováno v:
Journal of Clinical Oncology. 23:8389-8395
Purpose A phase III study to determine whether a weekly docetaxel schedule improves the therapeutic index compared with the classic 3-weekly schedule. Patients and Methods Patients with stage IIIB-IV non–small-cell lung cancer (NSCLC) were randomly
Autor:
Wilhelm Schmidt, Andreas Schöpfel, W. A. Stertmann, Jochen Kreuzer, Andreas Schuchert, Michael Jakob, Nobert Treese, Werner Jung, Ulrich Staedt, Thomas Meinertz
Publikováno v:
Pacing and Clinical Electrophysiology. 23:1263-1267
Atrial synchronous ventricular pacing seems to be the best pacing mode for patients with advanced AV block and impaired LV function. The long-term follow-up of single lead VDD pacing was studied in 33 patients with impaired LV function and compared t
Autor:
Gerhard W. Sybrecht, Katrin Korb, Karl Häußinger, You-Dschun Ko, Andreas Gröschel, Bettina Jilge, Karsten grosse Kreymborg, E-Wilhelm Schmidt, Norman Klopp, H-Erich Wichmann, Albert Rosenberger, Gabi Wölke, Eckart Meese, Dagmar Täuscher, Christine Schmidt, Thomas Illig, Harald Morr, Florian Kronenberg, Heike Bickeböller, Maria Degen, Matthias Cebulla, Nikolaus Konietzko, Peter Drings, Vera Zietemann, Gerd Höffken
Publikováno v:
BMC Cancer 8:60 (2008)
BMC Cancer, Vol 8, Iss 1, p 60 (2008)
BMC Cancer
BMC Cancer, Vol 8, Iss 1, p 60 (2008)
BMC Cancer
Background Early onset lung cancer shows some familial aggregation, pointing to a genetic predisposition. This study was set up to investigate the role of candidate genes in the susceptibility to lung cancer patients younger than 51 years at diagnosi
Autor:
Michael Thomas, Dorothea Riesenbeck, Achim Heinecke, Folker Klinke, Petra Hoffknecht, Ernst-Wilhelm Schmidt, D. Wewers, Normann Willich, Hans N. Macha, Andrea Schumacher, Michael Braunheim, Wolfgang E. Berdel, Michael Semik
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 44(1)
The German Lung Cancer Cooperative Group (GLCCG) is assessing the impact of chemoradiation in addition to chemotherapy in the neoadjuvant treatment of stage III NSCLC. After three cycles of cisplatin/etoposide patients receive either hyperfractionate
Autor:
Wilhelm Schmidt-Kessen
Publikováno v:
Digestion. 84:252-258
Autor:
Wilhelm Schmidt-Kessen
Publikováno v:
Digestion. 83:177-186
Autor:
Mathias Cebulla, Heinz-Erich Wichmann, Karl Haeußinger, You-Dschun Ko, Andreas Groeschel, Heike Bickeboeller, Gabi Woelke, Kirstin Mittelstrass, Jenny Chang-Claude, Maria Degen, Peter Drings, Wilhelm Schmidt, Norman Klopp, Eckart Meese, Gerd Hoeffken, Wiebke Sauter, Hendrik Dienemann, Harald Morr, Dagmar Taeuscher, Angela Risch, Maria Timofeeva, Thomas Illig, Karsten grosse Kreymborg, Gerhard W. Sybrecht, Christine Schmidt, Albert Rosenberger, Bettina Jilge
Publikováno v:
BMC Cancer, Vol 8, Iss 1, p 113 (2008)
BMC Cancer
BMC Cancer 8:113 (2008)
BMC Cancer
BMC Cancer 8:113 (2008)
The polymorphism SNP309 (rs2279744) in the promoter region of the MDM2 gene has been shown to alter protein expression and may play a role in the susceptibility to lung cancer. The MDM2 protein is a key inhibitor of p53 and several mechanisms of MDM2